SeekingAlpha · Feb 21, 2026
Freight Logistics Selloff Looks Mispriced: Why The AI Panic May Be Overdone
AI freight optimization isnât as disruptive as markets fear.
OTC · REMI
Remedent, Inc.
Healthcare · Medical - Instruments & Supplies
$0.00
Up+$0.00 (+0.00%)
Updated Nov 3, 2026, 7:10 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8K
- P/E ratio
- -0.03
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.05
- Volume
- 200K
- Avg. volume
- 10.05K
Price performance · REMI
REMI price history
1M range · 0 trading sessions · Daily adjusted prices
REMI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest REMI news
The latest Smart Investors Daily articles mentioning REMI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
REMI research
Overview
Company profile and research snapshot.
Company profile
REMEDENT INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
defenseworld.net · Nov 25, 2025
Reviewing Remedent (OTCMKTS:REMI) and Escalon Medical (OTCMKTS:ESMC)
Earnings and Valuation This table compares Escalon Medical and Remedent"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Escalon Medical $12.05 million 0.10 $110,000.00 ($0.02) -7.75 Remedent $990,000.00 0.01 -$270,000.00 ($0.01) -0.03 Escalon Medical has higher revenue and earnings than Remedent. Escalon Medical is trading at
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
